DEFSEC Technologies reports $7.7 million cash balance

• DEFSEC Technologies reported preliminary, unaudited cash and cash equivalents of approximately $7.7 million as of September 30, 2026, compared with $3.5 million at June 30.
• The company reported zero debt at both reporting dates, with 4,593,998 common shares outstanding and 24,575 unconverted pre-funded warrants as of October 20.
• DEFSEC is expanding its sales and marketing resources to support ARWEN products, while advancing commercialization activities following U.S. Army demonstrations of its BLISS technology.

DEFSEC Technologies (NASDAQ:DFSC) reported preliminary cash and cash equivalents of approximately $7.7 million at September 30, 2026, more than doubling its June balance.

Cash increased from approximately $3.5 million, reflecting August equity financing proceeds offset by fourth-quarter operating activities, while reported debt remained zero.

The improved cash position gives DEFSEC additional resources to pursue commercial growth, although the increase primarily reflects financing rather than operating profitability.

DEFSEC reported 4,593,998 outstanding common shares and 24,575 unconverted pre-funded warrants as of October 20, following its recent equity financing.

The company plans to expand business development and marketing to increase ARWEN sales and cross-sell public safety products, without providing quantified revenue guidance.

Meanwhile, ARWEN 40mm baton ammunition has entered full-rate production, expanding DEFSEC's product offering for compatible less-lethal launchers.

DEFSEC also completed BLISS pre-production demonstrations for the U.S. Army in August, building on earlier Army testing of its sensor technology.